Healthcare Patient Consent for Methylphenidate

Healthcare Patient Consent for Methylphenidate

Patient Information

Date of Birth:    Gender:    Phone:

Relationship:    Phone:

Prescriber and Insurance

Clinic/Practice:    License/UPIN:    Office Phone:

Policy Number:    Group Number:    Subscriber Name:

Medical and Medication History

History of substance misuse or current use of illicit drugs: Yes    Prior history of psychosis or mania: Yes

Medication Information and Intended Use

Medication to be prescribed: Methylphenidate (stimulant medication). Formulation and dose as determined by prescriber:

Indication:

Risks, Benefits and Alternatives

I understand the prescriber has explained the intended therapeutic benefits of methylphenidate, which may include improved attention, impulse control, and decreased hyperactivity. I acknowledge that improvement is not guaranteed and may vary.

Potential common side effects include decreased appetite, weight loss, insomnia, headache, dry mouth, nausea, increased heart rate, and elevated blood pressure. Less common but serious risks include cardiovascular events (such as arrhythmia, myocardial infarction, stroke), new or worsening psychiatric symptoms (including psychosis, mania, severe anxiety), seizures, or exacerbation of tics.

There is a risk of misuse, dependence, diversion, and illicit use. I agree not to share, sell, or divert this medication. I understand that the prescriber may require monitoring measures such as pill counts, pharmacy checks, urine drug screening, and regular follow-up visits.

Reasonable alternatives have been discussed, including non-stimulant medications, behavioral therapy, and non-pharmacologic interventions. I have had the opportunity to ask questions and understand the alternatives.

Precautions and Special Considerations

I confirm I have informed the prescriber if I have or had: heart problems, high blood pressure, circulation problems, hyperthyroidism, glaucoma, history of seizures, tics or Tourette's disorder, or a history of substance misuse.

Females of reproductive potential: I understand methylphenidate may present risks during pregnancy and breastfeeding. I confirm that I have discussed pregnancy plans and contraceptive needs with the prescriber. I agree to promptly notify the prescriber if pregnancy occurs or is suspected.

Patient Responsibilities and Monitoring

I agree to take this medication only as prescribed. I will maintain scheduled follow-up visits and monitoring (including blood pressure, heart rate, weight, and assessment of psychiatric symptoms). I will report any severe or concerning adverse effects immediately.

I will store medication securely and dispose of unused medication in accordance with safe disposal guidance. I consent to the prescriber's office contacting my pharmacy and insurance as necessary for treatment and coordination of care.

HIPAA and Information Release Acknowledgment

I acknowledge that I have received or been offered the facility's privacy practices and that I authorize the prescriber and clinic to use and disclose protected health information as necessary for treatment, payment, and healthcare operations related to this medication. I authorize communication with my pharmacy, insurance, and other healthcare providers as needed.

Acknowledgments and Initials

I have read and understand the information above and have had the opportunity to ask questions. I acknowledge the following by initialing each item:

Medication name, expected benefits, and common side effects explained.   Initials:

Risk of misuse, dependence, and diversion explained; I will not share medication.   Initials:

Need for monitoring and agreement to follow-up visits and potential testing.   Initials:

Authorization and Expiration

By signing below I authorize the prescriber to initiate or continue a prescription for methylphenidate as clinically indicated and to communicate with pharmacies and insurers for purposes of treatment and payment. I understand that I may withdraw consent at any time by notifying the prescriber in writing, but withdrawal will not affect actions already taken.

Consent

I voluntarily consent to the use of methylphenidate as described above. I have had the opportunity to discuss the risks, benefits, and alternatives and to have my questions answered. I understand that no guarantee has been made concerning the results of treatment.

Sign Now